4Q17

SINGAPORE (Apr 2): UOB Kay Hian is keeping Tianjin Zhongxin Pharmaceutical Group at “buy” with a higher target price of US$1.66 ($2.17), pegged to peer average of 14.1 times FY18 earnings.

SINGAPORE (Mar 1): Vard Holdings reported a doubling of 4Q17 losses to NOK 131 million ($22.2 million) from its net loss position of NOK 67 million a year ago.

SINGAPORE (Mar 1): Property developer Wee Hur Holdings saw earnings more than triple to $7.8 million in 4Q17 from $2.2 million in 4Q16 on the back of higher revenue.

SINGAPORE (Mar 1): Starburst Holdings, the firearms-training facilities provider, swung back into profitability in FY17 with earnings of $0.1 million compared to a loss of $11.7 million in FY16.

SINGAPORE (Mar 1): Hotel Royal posted a 92.5% decline in fourth quarter earnings to $0.2 million in 4Q17 compared to its earnings of $2.9 million in 4Q16 on the back of higher operating expenses.

SINGAPORE (Mar 1): Yongnam Holdings reported full-year losses narrowed by half to $15.8 million in FY17 from $31.6 million in FY16 on improved margins for some of its projects.  

SINGAPORE (Mar 1): UOB Kay Hian is maintaining its “buy” call on Singapore Medical Group (SMG) with a P/E-based target price of 83 cents, pegged to the peer average FY18 P/E ratio of 26.8 times.

SINGAPORE (Mar 1): Phillip Capital is maintaining “accumulate” on Asian Pay Television Trust (APTV) with a lower target price of 62 cents from 64 cents previously to account for lower ARPU and higher cash taxes in FY18.

SINGAPORE (Mar 1): DBS and CIMB are positive on the outlook of UMS Holdings, maintaining their respective “buy” calls with higher target prices after the group delivered record 4Q profits on higher revenue and a one-off gain.

SINGAPORE (Feb 28): Fu Yu Corporation posted 4Q17 earnings of $2.4 million for the 4Q ended Dec 2017, 56.8% down from $5.6 million a year ago on other operating expenses.